Sponsored by the North American Center for Continuing Medical Education (NACCME)
Target Audience
Physicians, nurses and technologists who treat patients with contrast induced nephropathy
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Define contrast induced nephropathy.
- Describe patients who are at high risk for contrast induced nephropathy and explain what factors lead to that risk.
- Summarize the clinical trial data involving hydration protocols for patients at risk for CIN.
- Develop treatment strategies to prevent contrast induced nephropathy.
- Implement a treatment algorithm for patients at low, moderate and high risk for contrast induced nephropathy before, during and post-procedure.
Activity Overview
To be eligible for documentation of credit, participants must read all article content, log on to www.naccme.com to complete the post-test with a score of 70% or better, and complete the online evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Please e-mail info@naccme.com or call 609-371-1137 if you have questions or need additional information.
For questions regarding this activity, please call 609-371-1137.
There is no fee for the activity.
Release Date: October 1, 2008
Expiration Date: October 1, 2010
CME Accreditation
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.
CNE Accreditation
NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 2 contact hours. Provider #: 110-3-E-06. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 2 contact hours.
AHRA Accreditation
Approved for 2 Category A, ARRT continuing education credits
Grant Support
This activity is supported by an educational grant from Bracco Diagnostics
Participating Faculty
Roxana Mehran, M.D
Columbia University Medical Center
Associate Professor of Medicine
Director of Outcomes Research
Data Coordination & Analysis for the Center for Interventional Vascular Therapies
Cardiovascular Research Foundation
Director of Data Coordinating & Analysis Center
New York, New York
Eugenia Nikolsky, MD, PhD
Director, Clinical Research in Interventional Cardiology, Department of Cardiology
Rambam Medical Center
Technion-Israel Institute of Technology
Israel
Director, Academy Affairs
Cardiovascular Research Foundation
New York, New York
Financial Disclosure and Conflicts of Interest
Off-Label/Unapproved Usage Discussion: This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither NACCME, nor Bracco Diagnostics recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclosures
All those in a position to control content of continuing education programs sponsored by NACCME, LLC are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Planning Committee: T. Levy, NACCME and J. Martin and R. Norris, HMP Communications have disclosed that they have no relevant financial relationship with any commercial interest.
Faculty/Author: R. Mehran, M.D. has disclosed that she has received grant/research support from The Medicines Company and Boston Scientific. She is a consultant to Abbott and Bracco and a member of the speakers’ bureau for Medtronic.
Faculty/Author: Dr. Nikolsky has disclosed no relevant financial relationship with any organization that could be perceived as a conflict of interest.
Editor: L. Gustafson, HMP Communications has disclosed that she has no relevant financial relationship with any commercial interest.
Reviewer: Dr. Dieter has disclosed that he has no relevant financial relationships with any organization that could be perceived as a conflict of interest.
